Anna has worked on a range of contentious and non-contentious intellectual property matters, including patent litigation in the life sciences sector and licence disputes.  She has also conducted due diligence and provided advice on the IP aspect of a large commercial transaction. Her life sciences work has involved pharmaceutical formulations, medical devices and vaccines.  She has experience in co-ordinating and conducting cross-border litigation involving parallel proceedings in the US and across Europe, as well as opposition proceedings before the European Patent Office.

Anna joined Powell Gilbert in 2019.

Key cases

• BioNTech / Pfizer v Moderna (SARS-CoV2 vaccine)
• Oxford University Innovations v Oxford Nanoimaging (entitlement dispute)
• Ocado v AutoStore (UPC – robotics)
• Otsuka v GW Pharma (royalty dispute / jurisdiction challenge – cannabidiol)
• Edwards Lifesciences v Meril (UPC – transcatheter heart valves)
• Abbott v Edwards Lifesciences (transcatheter mitral valve repair)
• Napp v Dr Reddy’s& Sandoz (cross undertaking damages inquiry)